Neutralization and Stability of SARS-CoV-2 Omicron Variant

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• The SARS-CoV-2 Omicron variant (B.1.1.529) emerged with a high number of spike protein mutations, raising concerns about immune evasion and transmissibility.
• Previous variants had fewer spike mutations (7-10), while Omicron possesses 30-40, potentially impacting vaccine effectiveness and viral spread.

Approach:

• Investigated Omicron's immune evasion compared to other variants.
• Assessed the impact of mRNA vaccine booster doses on antibody neutralization.
• Analyzed Omicron spike protein functionality, including receptor binding, cell fusion, and shedding.
• Utilized homology modeling to understand the structural stability of the Omicron spike protein.

Key Points:

• Omicron demonstrates significant immune evasion, but antibody neutralization is largely restored by mRNA vaccine booster doses.
• The Omicron spike protein exhibits reduced receptor binding, cell-cell fusion, and S1 subunit shedding.
• Conversely, Omicron shows increased cell-to-cell transmission, potentially due to enhanced spike protein stability and a more stable closed S structure.

Conclusions:

• Omicron employs dual strategies for immune evasion via altered epitopes and reduced receptor-binding domain exposure.
• Enhanced spike protein stability contributes to Omicron's increased transmissibility.
• Booster vaccine doses are crucial for maintaining protection against the Omicron variant, offering mechanistic insights into its altered spike protein functionality.